ATE439375T1 - Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden - Google Patents
Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methodenInfo
- Publication number
- ATE439375T1 ATE439375T1 AT05778354T AT05778354T ATE439375T1 AT E439375 T1 ATE439375 T1 AT E439375T1 AT 05778354 T AT05778354 T AT 05778354T AT 05778354 T AT05778354 T AT 05778354T AT E439375 T1 ATE439375 T1 AT E439375T1
- Authority
- AT
- Austria
- Prior art keywords
- tumour
- present
- immunotherapeutic methods
- relates
- immunogenic
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 230000001024 immunotherapeutic effect Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000000259 anti-tumor effect Effects 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 208000008839 Kidney Neoplasms Diseases 0.000 abstract 1
- 206010038389 Renal cancer Diseases 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 201000010982 kidney cancer Diseases 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04023546A EP1642905B1 (de) | 2004-10-02 | 2004-10-02 | Immunogene T-Helfer Epitope von menschlichen Tumorantigenen und deren Verwendung in immunotherapeutischen Methoden |
| PCT/EP2005/009719 WO2006037421A2 (en) | 2004-10-02 | 2005-09-09 | Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE439375T1 true ATE439375T1 (de) | 2009-08-15 |
Family
ID=34926825
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04023546T ATE421533T1 (de) | 2004-10-02 | 2004-10-02 | Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden |
| AT05778354T ATE439375T1 (de) | 2004-10-02 | 2005-09-09 | Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04023546T ATE421533T1 (de) | 2004-10-02 | 2004-10-02 | Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8067529B2 (de) |
| EP (2) | EP1642905B1 (de) |
| JP (2) | JP2008514208A (de) |
| AT (2) | ATE421533T1 (de) |
| AU (1) | AU2005291660B2 (de) |
| CA (1) | CA2583065A1 (de) |
| DE (2) | DE602004019215D1 (de) |
| ES (2) | ES2319286T3 (de) |
| PL (2) | PL1642905T3 (de) |
| SI (2) | SI1642905T1 (de) |
| WO (1) | WO2006037421A2 (de) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0609121D0 (en) * | 2006-05-09 | 2006-06-21 | Univ Birmingham | Peptide Therapy |
| US20090004213A1 (en) * | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| HUE032379T2 (en) | 2007-07-27 | 2017-09-28 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
| TW200932260A (en) * | 2007-11-28 | 2009-08-01 | Oncotherapy Science Inc | STAT3 epitope peptides |
| TW201000119A (en) * | 2008-06-10 | 2010-01-01 | Oncotherapy Science Inc | MYBL2 epitope peptides and vaccines containing the same |
| RS53782B1 (sr) * | 2008-10-01 | 2015-06-30 | Immatics Biotechnologies Gmbh | Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera |
| AU2016204711B2 (en) * | 2008-10-01 | 2018-03-01 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors including neuronal and brain tumors |
| AU2009301580B2 (en) * | 2008-10-06 | 2015-11-26 | The University Of British Columbia | Methods and systems for predicting misfolded protein epitopes |
| WO2011073215A2 (en) | 2009-12-14 | 2011-06-23 | Immatics Biotechnologies Gmbh | Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201009222D0 (en) | 2010-06-02 | 2010-07-21 | Immatics Biotechnologies Gmbh | Improved cancer therapy based on tumour associated antigens derived from cyclin D1 |
| CA2821582A1 (en) | 2010-12-14 | 2012-06-21 | Immatics Biotechnologies Gmbh | Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |
| EP2970496B1 (de) * | 2013-03-12 | 2018-07-18 | Institute of Arthritis Research LLC | Immunologisch aktives polypeptid |
| ES3009756T3 (en) | 2013-08-05 | 2025-03-31 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors, such as lung cancer including nsclc |
| WO2015104711A1 (en) | 2014-01-09 | 2015-07-16 | Hadasit Medical Research Services And Development Ltd. | Improved cell compositions and methods for cancer therapy |
| DK3122375T3 (da) | 2014-03-28 | 2021-05-25 | Univ Washington Through Its Center For Commercialization | Vacciner mod bryst- og ovariecancer |
| ES2702676T3 (es) * | 2014-04-01 | 2019-03-04 | Inst Nat Sante Rech Med | Péptido de donante aislado derivado de MHC y usos del mismo |
| WO2015150491A1 (en) * | 2014-04-01 | 2015-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An isolated donor mhc-derived peptide and uses thereof |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| HK1254866A1 (zh) * | 2015-06-25 | 2019-07-26 | Immatics Biotechnologies Gmbh | 用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物 |
| PH12022551111A1 (en) * | 2015-10-05 | 2023-08-23 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| GB201607535D0 (en) * | 2016-04-29 | 2016-06-15 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
| GB201521746D0 (en) | 2015-12-10 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers |
| EP3475706B1 (de) * | 2016-06-27 | 2021-08-11 | Juno Therapeutics, Inc. | Mhc-e-beschränkte epitopen, bindungsmoleküle, und zugehörige verfahren und verwendungen |
| JP7458318B2 (ja) | 2018-02-12 | 2024-03-29 | ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド | 癌治療のためのｓｌａｍｆ６スプライスバリアントの調節 |
| EP3894543A1 (de) * | 2018-12-14 | 2021-10-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Isolierte humane mhc-abgeleitete peptide und verwendungen davon zur stimulierung und aktivierung der suppressiven funktion von cd8cd45rc + cd45rc low tregs |
| SG11202111290WA (en) * | 2019-04-17 | 2021-11-29 | Codiak Biosciences Inc | Compositions of exosomes and aav |
| IL267614A (en) | 2019-06-24 | 2019-09-26 | Lotem Michal | Nucleic acids to modulate SLAMF6 isoforms |
| AU2022233019A1 (en) * | 2021-03-11 | 2023-09-28 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Tumor neoantigenic peptides |
| WO2025069022A1 (en) * | 2023-09-28 | 2025-04-03 | Hadasit Medical Research Services And Development Ltd. | Immunomodulating peptides and uses thereof |
| WO2025147634A1 (en) * | 2024-01-03 | 2025-07-10 | The Terasaki Innovation Center | Method of detecting human leukocyte antigens (hla) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0584264A1 (de) * | 1991-05-16 | 1994-03-02 | Cold Spring Harbor Laboratory | D-typ cyclin und darauf bezogene anwendungen |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| US5912167A (en) * | 1995-06-06 | 1999-06-15 | Wisconsin Alumni Research Foundation | Autocatalytic cleavage site and use thereof in a protein expression vector |
| CA2243235C (en) | 1996-01-17 | 2010-08-10 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
| GB9823897D0 (en) * | 1998-11-02 | 1998-12-30 | Imp College Innovations Ltd | Immunotherapeutic methods and molecules |
| CA2460959A1 (en) * | 2001-09-28 | 2003-05-22 | Incyte Genomics, Inc. | Enzymes |
| US20030194704A1 (en) * | 2002-04-03 | 2003-10-16 | Penn Sharron Gaynor | Human genome-derived single exon nucleic acid probes useful for gene expression analysis two |
| DE10225144A1 (de) * | 2002-05-29 | 2003-12-18 | Immatics Biotechnologies Gmbh | An MHC-Moleküle bindende Tumor-assoziierte Peptide |
| EP1369482A1 (de) * | 2002-06-07 | 2003-12-10 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Zielgene für die Diagnose und Behandlung von Krebs |
| CA2604852A1 (en) | 2005-04-15 | 2006-10-26 | Oncomethylome Sciences, S.A. | Methylation markers for diagnosis and treatment of cancers |
-
2004
- 2004-10-02 EP EP04023546A patent/EP1642905B1/de not_active Expired - Lifetime
- 2004-10-02 PL PL04023546T patent/PL1642905T3/pl unknown
- 2004-10-02 AT AT04023546T patent/ATE421533T1/de active
- 2004-10-02 SI SI200431004T patent/SI1642905T1/sl unknown
- 2004-10-02 DE DE602004019215T patent/DE602004019215D1/de not_active Expired - Lifetime
- 2004-10-02 ES ES04023546T patent/ES2319286T3/es not_active Expired - Lifetime
-
2005
- 2005-09-09 JP JP2007533893A patent/JP2008514208A/ja active Pending
- 2005-09-09 CA CA002583065A patent/CA2583065A1/en not_active Abandoned
- 2005-09-09 ES ES05778354T patent/ES2328945T3/es not_active Expired - Lifetime
- 2005-09-09 WO PCT/EP2005/009719 patent/WO2006037421A2/en not_active Ceased
- 2005-09-09 AT AT05778354T patent/ATE439375T1/de active
- 2005-09-09 DE DE602005015990T patent/DE602005015990D1/de not_active Expired - Lifetime
- 2005-09-09 US US11/664,627 patent/US8067529B2/en not_active Expired - Fee Related
- 2005-09-09 PL PL05778354T patent/PL1794190T3/pl unknown
- 2005-09-09 EP EP05778354A patent/EP1794190B9/de not_active Expired - Lifetime
- 2005-09-09 SI SI200530786T patent/SI1794190T1/sl unknown
- 2005-09-09 AU AU2005291660A patent/AU2005291660B2/en not_active Ceased
-
2011
- 2011-04-21 JP JP2011094758A patent/JP2011200231A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005291660B2 (en) | 2010-02-18 |
| WO2006037421A2 (en) | 2006-04-13 |
| PL1642905T3 (pl) | 2009-04-30 |
| JP2011200231A (ja) | 2011-10-13 |
| PL1794190T3 (pl) | 2010-01-29 |
| DE602005015990D1 (de) | 2009-09-24 |
| WO2006037421A3 (en) | 2006-06-29 |
| ES2319286T3 (es) | 2009-05-06 |
| CA2583065A1 (en) | 2006-04-13 |
| EP1642905B1 (de) | 2009-01-21 |
| EP1794190B1 (de) | 2009-08-12 |
| ATE421533T1 (de) | 2009-02-15 |
| SI1794190T1 (sl) | 2009-12-31 |
| DE602004019215D1 (de) | 2009-03-12 |
| US20090317428A1 (en) | 2009-12-24 |
| JP2008514208A (ja) | 2008-05-08 |
| AU2005291660A1 (en) | 2006-04-13 |
| ES2328945T3 (es) | 2009-11-19 |
| SI1642905T1 (sl) | 2009-04-30 |
| EP1794190A2 (de) | 2007-06-13 |
| EP1794190B9 (de) | 2010-05-19 |
| EP1642905A1 (de) | 2006-04-05 |
| US8067529B2 (en) | 2011-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE421533T1 (de) | Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden | |
| EA200800677A1 (ru) | Опухолеассоциированные пептиды, беспорядочно связывающиеся с молекулами класса ii человеческого лейкоцитарного антигена (hla) | |
| EA200800676A1 (ru) | Опухолеассоциированные пептиды, связывающиеся с молекулами человеческого лейкоцитарного антигена (hla) i или ii класса, и относящаяся к ним противораковая вакцина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1794190 Country of ref document: EP |